loader

Generation Bio Co.

NASDAQ:GBIO
Featured Articles and Interviews

Investing in Graphene Companies

Press Releases

Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results

Generation Bio Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms at the ASGCT 27th Annual Meeting

Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy 27th Annual Meeting

Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina related diseases.

Interactive Chart